Gliclazide, a K<sub>ATP</sub> channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway.
| Author | |
|---|---|
| Year of Publication |
:
2018
|
| Journal |
:
Vascular pharmacology
|
| Date Published |
:
2018
|
| ISSN Number |
:
1537-1891
|
| DOI |
:
10.1016/j.vph.2018.01.001
|
| Short Title |
:
Vascul Pharmacol
|
| Download citation |
